Log in
Enquire now
‌

US Patent 11801271 Stable bacterial extracts as pharmaceuticals

Patent 11801271 was granted and assigned to OM Pharma on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
OM Pharma
OM Pharma
Current Assignee
OM Pharma
OM Pharma
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11801271
Patent Inventor Names
Christian Pasquali
Jacques Bauer
Date of Patent
October 31, 2023
Patent Application Number
17474242
Date Filed
September 14, 2021
Patent Primary Examiner
‌
Lora E Barnhart Driscoll
CPC Code
‌
A61K 9/0078
‌
A61K 9/08
‌
A61K 39/39
‌
A61K 47/02
‌
A61K 35/74
‌
A61P 31/14
‌
A61P 29/00
‌
A61P 31/00
...
Patent abstract

The present invention relates to novel stable bacterial extract preparations having substantial increased stability over time, novel methods of preparation thereof, pharmaceutical formulations based on these novel stabilized bacterial extracts, as well as novel routes of administration and delivery devices for treating and/or preventing acute and chronic immunological disorders resulting from infections and/or inflammation and/or neoplasms and/or dysbiosis.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11801271 Stable bacterial extracts as pharmaceuticals

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.